{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:24:39Z","timestamp":1790612679835,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1212\/wnl.0b013e3181e0f7e6","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T23:16:47Z","timestamp":1272496607000},"page":"1822-1826","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":86,"title":["Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS"],"prefix":"10.1212","volume":"74","author":[{"given":"E.","family":"Kingwell","sequence":"first","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koch","sequence":"additional","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Leung","sequence":"additional","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Isserow","sequence":"additional","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Geddes","sequence":"additional","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rieckmann","sequence":"additional","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tremlett","sequence":"additional","affiliation":[{"name":"From the Faculty of Medicine, Division of Neurology (E.K., M.K., B.L., P.R., H.T.), and Faculty of Medicine, Division of Cardiology (S.I.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Nursing (J.G.), Vancouver Coastal Health, British Columbia, Canada; and Department of Neurology (M.K.), University Medical Center Groningen, University of Groningen; Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.2.112"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050066"},{"key":"e_1_3_3_4_2","first-page":"210","volume":"101","year":"2001","unstructured":"van de Wyngaert FA, Beguin C, D'Hooghe MB, et al. A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. Acta Neurol Belg 2001;101:210\u2013216.","journal-title":"Acta Neurol Belg"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)12023-X"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022040-00002"},{"key":"e_1_3_3_7_2","first-page":"609","volume":"71","year":"1987","unstructured":"Mather FJ, Simon RM, Clark GM, Von Hoff DD. Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies. Cancer Treat Rep 1987;71:609\u2013613.","journal-title":"Cancer Treat Rep"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.6.909"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02191555"},{"key":"e_1_3_3_10_2","first-page":"S28","volume":"63","year":"2004","unstructured":"Cohen BA, Mikol DD. Mitoxantrone treatment of multiple sclerosis: safety considerations. Neurology 2004;63:S28\u2013S32.","journal-title":"Neurology"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2004.04.018"},{"key":"e_1_3_3_12_2","first-page":"111","volume":"9","year":"2006","unstructured":"Hamzehloo A, Etemadifar M. Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis. Arch Iran Med 2006;9:111\u2013114.","journal-title":"Arch Iran Med"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms896oa"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.091033"},{"key":"e_1_3_3_15_2","unstructured":"Hum S Lapierre Y. A clinical retrospective report on mitoxantrone treatment in active multiple sclerosis patients. Neurology 2009;72:A237. Abstract."},{"key":"e_1_3_3_16_2","unstructured":"Rivera V Weinstock-Guttman B Beagan J Bennet R Al-Sabbagh A Dangond F. Final results from the registry to evaluate Novantrone. Mult Scler 2009;15:S254. Abstract."},{"key":"e_1_3_3_17_2","unstructured":"US Department of Health and Human Services National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2009. Available at: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.02_2009-09-15_QuickReference_8.5x11.pdf. Accessed January 19 2010."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087242"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.124958"},{"key":"e_1_3_3_20_2","unstructured":"US Food and Drug Administration. Mitoxantrone Hydrochloride (marketed as Novantrone and generics)\u2014Healthcare Professional Sheet. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm126445.htm. Accessed August 20 2009."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00400.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238515.27055.62"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3181e0f7e6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T08:56:53Z","timestamp":1711616213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3181e0f7e6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":21,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1212\/WNL.0b013e3181e0f7e6"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3181e0f7e6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3606957.3319057","asserted-by":"object"}]},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}